Evidence map›Paper›PMID 42729460›Full record

ReviewEClinicalMedicine2026

The benchmark illusion: on the curious underestimation of AI and the uncertainty of its creators' gold standards.

Christian Pohlkamp, Torsten Haferlach

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christian PohlkampMLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
Torsten HaferlachMLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) systems have quietly crossed an uncomfortable threshold: on a growing range of diagnostic tasks, they often match, and in some well-defined tasks even exceed, human performance. Evidence from large language models such as Med-PaLM and GPT-4, and deep learning systems in pathology, radiology, and hematology, shows high accuracy and reproducibility, challenging traditional human benchmarks, although still being subject to substantial heterogeneity in the studies cited. Yet most evaluation frameworks continue to treat human consensus on curated, retrospectively labeled datasets as ground truth, despite well-documented record of cognitive bias, interobserver variability, and diagnostic errors in clinical practice. This creates a striking asymmetry: AI is scrutinized against a putative gold standard whose gold content has never been formally tested-a benchmark illusion. Acknowledging AI's own distinctive failure modes and generalizability problems, this Viewpoint argues that such limitations do not justify clinging to an untested reference. It calls for explicit modeling of ground truth uncertainty, outcome-based validation, and, where appropriate, using AI as an additional reference layer for human performance. The relevant benchmark is no longer clinicians alone, but the human-AI ensemble evaluated within real diagnostic ecosystems and against patient-relevant outcomes. Funding: None.

Indexed as

Artificial intelligenceDiagnostic benchmarkingGround truth uncertaintyHuman–AI ensemble

Identifiers

PMID42729460
PMCPMC13562412

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.